Global Genetic Testing Market Research Report 2012-2024
Table of Contents
1 Market Overview
- 1.1 Objectives of Research
- 1.1.1 Definition
- 1.1.2 Specifications
- 1.2 Market Segment
- 1.2.1 by Type
- 1.2.1.1 Newborn Screening
- 1.2.1.2 Diagnostic Testing
- 1.2.1.3 Carrier Testing
- 1.2.1.4 Preimplantation Genetic Diagnosis
- 1.2.1.5 Prenatal Diagnosis
- 1.2.1.6 Predictive and Presymptomatic Testing
- 1.2.1.7 Pharmacogenomics
- 1.2.2 by Application
- 1.2.2.1 Cardiology
- 1.2.2.2 Dermatology
- 1.2.2.3 Hematology
- 1.2.2.4 Hereditary Cancer
- 1.2.2.5 Immunology
- 1.2.2.6 Metabolic Disorders and Newborn Screening
- 1.2.2.7 Neurology
- 1.2.2.8 Ophthalmology
- 1.2.2.9 Pediatric Genetics
- 1.2.2.10 Others
- 1.2.3 by Regions
- 1.2.1 by Type
2 Industry Chain
- 2.1 Industry Chain Structure
- 2.2 Upstream
- 2.3 Market
- 2.3.1 SWOT
- 2.3.2 Dynamics
3 Environmental Analysis
- 3.1 Policy
- 3.2 Economic
- 3.3 Technology
- 3.4 Market Entry
4 Market Segmentation by Type
- 4.1 Market Size
- 4.1.1 Newborn Screening Market, 2013-2018
- 4.1.2 Diagnostic Testing Market, 2013-2018
- 4.1.3 Carrier Testing Market, 2013-2018
- 4.1.4 Preimplantation Genetic Diagnosis Market, 2013-2018
- 4.1.5 Prenatal Diagnosis Market, 2013-2018
- 4.1.6 Predictive and Presymptomatic Testing Market, 2013-2018
- 4.1.7 Pharmacogenomics Market, 2013-2018
- 4.2 Market Forecast
- 4.2.1 Newborn Screening Market Forecast, 2019-2024
- 4.2.2 Diagnostic Testing Market Forecast, 2019-2024
- 4.2.3 Carrier Testing Market Forecast, 2019-2024
- 4.2.4 Preimplantation Genetic Diagnosis Market Forecast, 2019-2024
- 4.2.5 Prenatal Diagnosis Market Forecast, 2019-2024
- 4.2.6 Predictive and Presymptomatic Testing Market Forecast, 2019-2024
- 4.2.7 Pharmacogenomics Market Forecast, 2019-2024
5 Market Segmentation by Application
- 5.1 Market Size
- 5.1.1 Cardiology Market, 2013-2018
- 5.1.2 Dermatology Market, 2013-2018
- 5.1.3 Hematology Market, 2013-2018
- 5.1.4 Hereditary Cancer Market, 2013-2018
- 5.1.5 Immunology Market, 2013-2018
- 5.1.6 Metabolic Disorders and Newborn Screening Market, 2013-2018
- 5.1.7 Neurology Market, 2013-2018
- 5.1.8 Ophthalmology Market, 2013-2018
- 5.1.9 Pediatric Genetics Market, 2013-2018
- 5.1.10 Others Market, 2013-2018
- 5.2 Market Forecast
- 5.2.1 Cardiology Market Forecast, 2019-2024
- 5.2.2 Dermatology Market Forecast, 2019-2024
- 5.2.3 Hematology Market Forecast, 2019-2024
- 5.2.4 Hereditary Cancer Market Forecast, 2019-2024
- 5.2.5 Immunology Market Forecast, 2019-2024
- 5.2.6 Metabolic Disorders and Newborn Screening Market Forecast, 2019-2024
- 5.2.7 Neurology Market Forecast, 2019-2024
- 5.2.8 Ophthalmology Market Forecast, 2019-2024
- 5.2.9 Pediatric Genetics Market Forecast, 2019-2024
- 5.2.10 Others Market Forecast, 2019-2024
6 Market Segmentation by Region
- 6.1 Market Size
- 6.1.1 Asia-Pacific
- 6.1.1.1 Asia-Pacific Market, 2012-2018
- 6.1.1.2 Asia-Pacific Market by Type
- 6.1.1.3 Asia-Pacific Market by Application
- 6.1.2 North America
- 6.1.2.1 North America Market, 2012-2018
- 6.1.2.2 North America Market by Type
- 6.1.2.3 North America Market by Application
- 6.1.3 Europe
- 6.1.3.1 Europe Market, 2012-2018
- 6.1.3.2 Europe Market by Type
- 6.1.3.3 Europe Market by Application
- 6.1.4 South America
- 6.1.4.1 South America Market, 2012-2018
- 6.1.4.2 South America Market by Type
- 6.1.4.3 South America Market by Application
- 6.1.5 Middle East & Africa
- 6.1.5.1 Middle East & Africa Market, 2012-2018
- 6.1.5.2 Middle East & Africa Market by Type
- 6.1.5.3 Middle East & Africa Market by Application
- 6.1.1 Asia-Pacific
- 6.2 Market Forecast
- 6.2.1 Asia-Pacific Market Forecast, 2019-2024
- 6.2.2 North America Market Forecast, 2019-2024
- 6.2.3 Europe Market Forecast, 2019-2024
- 6.2.4 South America Market Forecast, 2019-2024
- 6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
- 7.1 Global Market by Vendors
- 7.2 Market Concentration
- 7.3 Price & Factors
- 7.4 Marketing Channel
8 Major Vendors
- 8.1 GeneDx
- 8.2 Invitae
- 8.3 Pathway Genomics
- 8.4 Counsyl Inc
- 8.5 Asper Biotech
- 8.6 GenePlanet
- 8.7 Courtagen Life Sciences
- 8.8 Gene By Gene
- 8.9 Natera Inc
- 8.10 Regulatory
- 8.11 GeneTests
- 8.12 United Gene
- 8.13 HI Gene
- 8.14 Berry Genomics
- 8.15 23andMe Inc
- 8.16 360Jiyin
- 8.17 Novogene
- 8.18 CapitalBio
- 8.19 Agen
- 8.20 Biomedlab
- 8.21 Biomarker
- 8.22 Annoroad
- 8.23 Aiyin Gene
- 8.24 Aijiyin
- 8.25 Repconex
- 8.26 Find Bio-Tech
- 8.27 SinoGenoMax
- 8.28 Gene Kang
- 8.29 Geeppine
- 8.30 BGI
9 Conclusion
Summary
The global Genetic Testing market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Newborn Screening
Diagnostic Testing
Carrier Testing
Preimplantation Genetic Diagnosis
Prenatal Diagnosis
Predictive and Presymptomatic Testing
Pharmacogenomics
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
GeneDx
Invitae
Pathway Genomics
Counsyl Inc
Asper Biotech
GenePlanet
Courtagen Life Sciences
Gene By Gene
Natera Inc
Regulatory
GeneTests
United Gene
HI Gene
Berry Genomics
23andMe Inc
360Jiyin
Novogene
CapitalBio
Agen
Biomedlab
Biomarker
Annoroad
Aiyin Gene
Aijiyin
Repconex
Find Bio-Tech
SinoGenoMax
Gene Kang
Geeppine
BGI
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Cardiology
Dermatology
Hematology
Hereditary Cancer
Immunology
Metabolic Disorders and Newborn Screening
Neurology
Ophthalmology
Pediatric Genetics
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa